George W. Lloyd - May 26, 2022 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Signature
/s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd
Stock symbol
RPRX
Transactions as of
May 26, 2022
Transactions value $
-$4,029,091
Form type
4
Date filed
5/31/2022, 05:19 PM
Previous filing
May 25, 2022
Next filing
Jul 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Sale -$3.46M -86K -16.23% $40.21 444K May 26, 2022 By GWL 2014 G, LLC F1
transaction RPRX Class A Ordinary Shares Sale -$570K -14K -3.15% $40.77 430K May 27, 2022 By GWL 2014 G, LLC F2
holding RPRX Class A Ordinary Shares 496K May 26, 2022 By GWL 2013 NG, LLC
holding RPRX Class A Ordinary Shares 240K May 26, 2022 By GWL 2020 G, LLC
holding RPRX Class A Ordinary Shares 3K May 26, 2022 Direct
holding RPRX Class A Ordinary Shares 274K May 26, 2022 By IRA
holding RPRX Class A Ordinary Shares 4.01K May 26, 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.26 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.67 to $40.89 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.